FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental surgery, and can be used for simulating an infected wound with background of long-term current diabetes in experiment. Alloxan 200 mg/kg is administered on an empty stomach, 15 minutes after alloxan introduction, remaxol solution is administered intraperitoneally 13 ml/kg. Then, in 93 days, skin is excised in an inter-blade area to a superficial fascia in the form of a circle with diameter of 40 mm on the surface of the bottom of the formed wound, and the superficial fascia is dissected by transverse and longitudinal mutually perpendicular incisions. A purse-string suture is applied along the wound edges; the suture is tightened to bring the wound up to 20 mm in diameter; skin-facial nodal sutures are applied. Then, a gauze swab with a suspension of a daily culture of a polyantibiotic-resistant clinical strain of Staphylococcus aureus in dose of 2 billion microbial bodies in 1 ml of physiologic saline is introduced into the wound.
EFFECT: method enables simulating an infected wound with a background of long-term current diabetes mellitus with all the morphological features characteristic of it by simulating long-term current diabetes mellitus by an alloxan model of diabetes mellitus and using the remaxol preparation possessing high hepatoprotective and antioxidant action, and by simulating the infected wound by introducing a Staphylococcus aureus into the wound.
1 cl, 4 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING INFECTED WOUNDS IN RATS WITH BACKGROUND OF LONG-TERM CURRENT DIABETES MELLITUS | 2020 |
|
RU2741931C1 |
METHOD FOR SIMULATING TROPHIC WOUND IN EXPERIMENT | 2013 |
|
RU2510083C1 |
METHOD FOR CORRECTION OF ENDOTHELIAL DYSFUNCTION IN CARBOHYDRATE METABOLISM DISORDERS ACCOMPANIED BY END-STAGE INSULIN DEFICIENCY | 2020 |
|
RU2751414C1 |
METHOD OF VENOUS ETIOLOGY TROPHIC ULCER SIMULATION IN EXPERIMENT | 2016 |
|
RU2618653C1 |
METHOD OF PHARMACOLOGICAL CORRECTION OF POST-TRAUMATIC DISORDERS OF IMMUNITY AND REPARATIVE PROCESSES IN EXPERIMENT | 2018 |
|
RU2698801C1 |
METHOD FOR MODELING TROPHIC PURULENT WOUNDS IN EXPERIMENT | 2021 |
|
RU2753955C1 |
METHOD OF TROPHIC ULCER MODELING IN EXPERIMENT | 2018 |
|
RU2688460C1 |
METHOD OF TREATING INFECTED WOUNDS IN EXPERIMENT | 2010 |
|
RU2460553C1 |
2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE AND NICOTINIC ACID SALT, HAVING HYPOGLYCEMIC, HYPOLIPIDEMIC AND NEUROPROTECTIVE ACTIVITY AND SYNTHESIS METHOD THEREOF | 2010 |
|
RU2454406C2 |
METHOD FOR SIMULATING LONG-TERM NON-HEALING WOUNDS TO ASSESS WOUND-HEALING ACTION OF BIOMEDICAL CELL PRODUCTS | 2018 |
|
RU2702603C1 |
Authors
Dates
2020-11-06—Published
2020-06-08—Filed